By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Debiopharm 

Chemin Messidor 5-7
Case Postale 5911
Lausanne    CH - 1002  Switzerland
Phone: 41-21-321-0111 Fax: 41-21-321-0169


SEARCH JOBS








Company News
Debiopharm Reaches Important Development Milestones For Its Staphylococcus-Selective Antibiotic Debio 1450 10/25/2016 11:57:08 AM
Debiopharm Reaches Important Development Milestones For Its Staphylococcus-Selective Antibiotic Debio 1450 10/25/2016 9:47:15 AM
Debiopharm Announces Clinical Collaboration With Merck KGaA (MKGAF.PK), Darmstadt, Germany, And Pfizer (PFE) In Cancer Immunotherapy 10/20/2016 8:35:27 AM
The Japanese Cancer Association And Debiopharm Announce Winners Of The 2016 JCA-Mauvernay Award 10/7/2016 7:55:23 AM
Debiopharm Dumps Double Digit Millions Into Canadian Startup GenePOC 8/30/2016 9:44:49 AM
Debiopharm Initiates Clinical Phase II Study Evaluating Debio 1143 In Ovarian Cancer 6/7/2016 10:23:02 AM
FDA Grants Orphan Drug Designation To Debiopharms IAP Inhibitor Debio 1143 In The Treatment Of Ovarian Cancer 6/2/2016 6:32:01 AM
Debiopharm Donates To IMD To Promote Best Practice In Family Business Philanthropy 5/11/2016 9:10:35 AM
Debiopharm Announces Presentation At AACR Of Non-Clinical Data Relating To Its Targeted Investigational Compound Debio 1347/CH5183284, A Selective FGFR 1,2,3 Inhibitor 4/15/2016 8:14:27 AM
Debiopharm To Present The Latest Findings On Debio 1450 At ECCMID 4/8/2016 11:07:20 AM
12345678910...
//-->